BCM

BML Capital Management Portfolio holdings

AUM $131M
1-Year Est. Return 89.45%
This Quarter Est. Return
1 Year Est. Return
+89.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$124M
AUM Growth
-$37.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
31
New
Increased
Reduced
Closed

Top Buys

1
+$13.3M
2
+$2.49M
3
+$2.07M
4
KZR icon
Kezar Life Sciences
KZR
+$1.75M
5
ELEV
Elevation Oncology
ELEV
+$1.53M

Top Sells

1
+$26.1M
2
+$506K
3
+$373K
4
LENZ
LENZ Therapeutics
LENZ
+$268K
5
LSTA icon
Lisata Therapeutics
LSTA
+$159K

Sector Composition

1 Healthcare 98.84%
2 Technology 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HLVX
26
DELISTED
HilleVax
HLVX
$30.1K 0.02%
20,760
SGOV icon
27
iShares 0-3 Month Treasury Bond ETF
SGOV
$57.6B
– –
-260,000
LENZ
28
LENZ Therapeutics
LENZ
$1.16B
– –
-9,271
PVLA
29
Palvella Therapeutics
PVLA
$809M
– –
-42,130
KLRS
30
Kalaris Therapeutics
KLRS
$86.6M
– –
-8,011
ACHL
31
DELISTED
Achilles Therapeutics
ACHL
$0 ﹤0.01%
3,804,921
-295,081
1
2